Average Co-Inventor Count = 2.09
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (21 from 3,685 patents)
2. E. R. Squibb Sons, Inc. (16 from 1,624 patents)
3. Other (2 from 832,880 patents)
4. Britsol-myers Squibb Company (1 from 3 patents)
5. Squibb & Sons, Inc. (0 patent)
6. Misra, Raj N. (0 patent)
40 patents:
1. 7655689 - Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
2. 7569725 - Anthranilic acid derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase 3
3. 7517904 - Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
4. 7470797 - Fused heterocyclic imido and amido compounds
5. 7417040 - Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
6. 7141578 - Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
7. 6897321 - Process for preparing azacycloalkanoylaminothiazoles (LD 137e)
8. 6720347 - Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
9. 6639074 - Process for preparing azacycloalkanoylaminothiazoles
10. 6613911 - Process for preparing arylacetylaminothiazoles
11. 6521759 - Aminothiazole inhibitors of cyclin dependent kinases
12. 6515004 - N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
13. 6448264 - Use of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]-pyridines as cyclin dependent kinase inhibitors
14. 6414156 - Process for preparing azacycloalkanoylaminothiazoles
15. 6407124 - Carbon substituted aminothiazole inhibitors of cyclin dependent kinases